These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 32989209)
1. Recent classifications systems for gastroenteropancreatic neuroendocrine tumors A single-center experience. Yagmur Y; Söğutcü N; Gümüş S Ann Ital Chir; 2020; 91():598-604. PubMed ID: 32989209 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
3. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
4. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors. Karakuş E; Helvacı A; Ekinci O; Dursun A Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137 [TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181 [TBL] [Abstract][Full Text] [Related]
6. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? Grillo F; Albertelli M; Annunziata F; Boschetti M; Caff A; Pigozzi S; Ferone D; Mastracci L Endocrine; 2016 Jul; 53(1):58-62. PubMed ID: 26362059 [TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria. Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925 [TBL] [Abstract][Full Text] [Related]
9. Pathology - grading and staging of GEP-NETs. Capelli P; Fassan M; Scarpa A Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914 [TBL] [Abstract][Full Text] [Related]
10. High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis. Hayes AR; Furnace M; Shah R; Rundell C; Muller G; Dehbi HM; Luong TV; Toumpanakis C; Caplin ME; Krell D; Thirlwell C; Mandair D Pancreas; 2021 Apr; 50(4):516-523. PubMed ID: 33939663 [TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
13. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations. Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors. Özaslan E; Demir S; Karaca H; Güven K Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127 [TBL] [Abstract][Full Text] [Related]
15. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification. Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A Tunis Med; 2016 Oct; 94(8-9):580-586. PubMed ID: 28685792 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Estrozi B; Bacchi CE Clinics (Sao Paulo); 2011; 66(10):1671-5. PubMed ID: 22012036 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications. Fazio N; Milione M Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009 [TBL] [Abstract][Full Text] [Related]
19. Classification of neuroendocrine tumors. Klöppel G Verh Dtsch Ges Pathol; 1997; 81():111-7. PubMed ID: 9474861 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]